Aspire Biopharma Holdings, Inc. - 8-K Filing
Aspire Biopharma Holdings stockholders approved three proposals on June 16, 2026. The first authorized the issuance of shares upon exercise of warrants at $0.00001 per share; it received 1,742,683 votes for and 107,523 against. The second approved an adjustment to the number of shares issuable under the warrants with 1,745,709 in favor and 103,550 opposed. The third proposal adjusted the exercise price of the warrants; it received 1,739,702 votes for and 110,483 against. (Items: 5.07 Submission of Matters to a Vote of Security Holders)
Tickers: $ASBP